Metastases to the pituitary gland: insights from the German pituitary tumor registry.


Journal

Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578

Informations de publication

Date de publication:
Dec 2023
Historique:
accepted: 20 10 2023
medline: 24 11 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: ppublish

Résumé

Metastatic involvement of the pituitary gland is a rare but clinically significant phenomenon, that often poses diagnostic and therapeutic challenges. The aim of this study was to provide a comprehensive analysis of the origin of pituitary metastases using data from the German Pituitary Tumor Registry, one of the globally largest collections of pituitary pathology specimens. Here, we report data from a retrospective analysis of patients with metastases to the pituitary registered between 1990 and 2022. Out of 17,896 pituitary cases in the registry during this period, a total of 96 metastases to the pituitary gland were identified, accounting for 0.5% of all pituitary tumors in the registry. The mean age of the patients was 64 years. Breast cancer was identified as the primary tumor in 25% of total cases (n = 24/96) and in 50% of female patients. The second most prevalent primary tumor was lung cancer (18.75%, n = 18/96), followed by renal cell carcinoma (14.58%, n = 14/96). In comparison to current meta-analyses, this cohort shows a higher prevalence of metastases originating from the kidney. Furthermore, in contrast to the existing literature, no case of primary thyroid tumor was identified. Our study highlights the importance of pituitary metastases as a differential diagnosis in patients presenting with pituitary tumors.

Identifiants

pubmed: 37899389
doi: 10.1007/s11102-023-01361-0
pii: 10.1007/s11102-023-01361-0
pmc: PMC10665242
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

708-715

Informations de copyright

© 2023. The Author(s).

Références

Eur J Endocrinol. 2007 Feb;156(2):203-16
pubmed: 17287410
World Neurosurg. 2023 Apr;172:e684-e694
pubmed: 36764447
World Neurosurg. 2017 Oct;106:254-265
pubmed: 28673886
J Endocrinol Invest. 2007 May;30(5):428-33
pubmed: 17598977
Arch Pathol Lab Med. 2001 Jul;125(7):935-8
pubmed: 11419981
Int J Surg Case Rep. 2020;67:98-101
pubmed: 32058309
Cancer. 1970 Feb;25(2):478-80
pubmed: 5413515
Oncogene. 2000 Feb 21;19(8):1072-6
pubmed: 10713692
Nat Rev Urol. 2018 Aug;15(8):511-521
pubmed: 29904105
Nuklearmedizin. 2022 Apr;61(2):87-96
pubmed: 35299276
J Neurosurg. 2015 Oct;123(4):998-1007
pubmed: 26186025
Surg Neurol. 2009 Sep;72(3):248-55; discussion 255-6
pubmed: 18786712
Anticancer Drugs. 2018 Aug;29(7):710-715
pubmed: 29846249
J Clin Endocrinol Metab. 2004 Feb;89(2):574-80
pubmed: 14764764
Neurosurg Focus. 2004 Apr 15;16(4):E8
pubmed: 15191337
J Clin Endocrinol Metab. 1996 Oct;81(10):3455-9
pubmed: 8855784
Pituitary. 2023 Oct;26(5):583-596
pubmed: 37640885
Endocr Connect. 2018 Aug 23;:
pubmed: 30139817
J Neurooncol. 2023 Jan;161(1):175-184
pubmed: 36617600
Pituitary. 2014 Dec;17(6):575-87
pubmed: 24337713
Oncologist. 2020 May;25(5):e789-e797
pubmed: 31784491
Pituitary. 2018 Oct;21(5):463-473
pubmed: 29974330
Br J Neurosurg. 1989;3(1):71-9
pubmed: 2789715
J Natl Compr Canc Netw. 2021 Feb 12;19(4):432-438
pubmed: 33578374
World Neurosurg. 2013 Feb;79(2):327-30
pubmed: 22480977
Pathologe. 1985 Nov;6(6):308-12
pubmed: 4088978
Pituitary. 2015 Feb;18(1):159-68
pubmed: 24445565
Neurology. 1981 Aug;31(8):998-1002
pubmed: 7196526
Endocr Relat Cancer. 2020 Jan;27(1):R1-R20
pubmed: 31645015
Pituitary. 2017 Oct;20(5):489-498
pubmed: 28884415
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3379-3388
pubmed: 30892659
Eur J Endocrinol. 2018 Jan;178(1):G1-G24
pubmed: 29046323
J Neurooncol. 2020 Jan;146(2):219-227
pubmed: 31933258
Hormones (Athens). 2022 Dec;21(4):653-663
pubmed: 35947342
Pituitary. 2022 Dec;25(6):948-958
pubmed: 36203008
J Neurooncol. 2017 Mar;132(1):127-133
pubmed: 28070828
J Clin Endocrinol Metab. 1987 Sep;65(3):469-74
pubmed: 3624409
Pituitary. 2023 Oct;26(5):538-550
pubmed: 37698666
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):3959-3963
pubmed: 35947178
Thyroid. 2019 Apr;29(4):461-470
pubmed: 30900516
Eur J Endocrinol. 2023 Jun 7;188(6):519-525
pubmed: 37314433
Endocr Relat Cancer. 2008 Mar;15(1):37-49
pubmed: 18310274

Auteurs

Linus Haberbosch (L)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany. linus.haberbosch@charite.de.
Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany. linus.haberbosch@charite.de.
BIH Charité Junior Digital Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Charitéplatz 1, Berlin, 10117, Germany. linus.haberbosch@charite.de.

Simone Schmid (S)

Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.
Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.

Vanessa Hubertus (V)

Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.
Department of Neurosurgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
BIH Charité Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Charitéplatz 1, Berlin, 10117, Germany.

Dominik Soll (D)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.

Güliz Acker (G)

Department of Neurosurgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
Department of Radiation Oncology and Radiotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.

Matthias Dottermusch (M)

Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.

Marie Jensen (M)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.

Lukas Maurer (L)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.

Joachim Spranger (J)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.

Knut Mai (K)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.

Peter Vajkoczy (P)

Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.
Department of Neurosurgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.

Wolfgang Saeger (W)

Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Institute of Pathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.

Christian J Strasburger (CJ)

Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, 10117, Germany.
Pituitary Tumor Center of Excellence, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH